Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction

Pharmacotherapy

Volumn 27, Issue 9 I, 2007, Pages 1231-1236

  Raissy, Hengameh H ^a   Harkins, Michelle ^a   Esparham, Anna ^a   Kelly, H William ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Levalbuterol; Methacholine induced bronchoconstriction; R albuterol; S albuterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; LEVALBUTEROL; METHACHOLINE; NITRIC OXIDE; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; HUMAN; NEBULIZATION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ALBUTEROL; AREA UNDER CURVE; ASTHMA; BREATH TESTS; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ANTAGONISM; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; METHACHOLINE CHLORIDE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; STEREOISOMERISM;

EID: 34548356923     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.9.1231     Document Type: Article

References (16)

1. Berger WE. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma. Ann Allergy Asthma Immunol 2003;90:583-92.
2. 2- adrenoceptor agonists: is there a cause for concern? J Allergy Clin Immunol 1999;103:742-8.
3. Carl JC, Myers T, Kirchner HL, Kerscmar CM. Comparison of levalbuterol and racemic albuterol for treatment of acute asthma. J Pediatr 2003;143:731-6.
4. Nowak RM, Emerman CL, Schaefer K, DiSantostefano RL, Vaickus L. Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study Am J Emerg Med 2004;22:29-36.
5. Nowak R, Emerman C, Hanrahan JP, et al. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med 2006;24:259-67.
6. Baramki D, Koester J, Anderson AJ, Borish L. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: antiinflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 2002;109:449-54.
7. Hancox RJ, Aldridge RE, Cowan JO. Tolerance to β-agonists during acute bronchoconstriction. Eur Respir J 1999;14:283-7.
8. Jones SL, Cowan JO, Flannery EM, et al. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol. Eur Respir J 2001;17:368-73.
9. National Heart, Lung, and Blood Institute. National asthma education and prevention program, expert panel report 2. Guidelines for the diagnosis and management of asthma. National Institutes of Health publication no. 97-4051. Bethesda, MD: U.S. Department of Health and Human Services; 1997.
10. Cockcroft DW, Swystun VA. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax 1997;52:845-8.
11. 2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. J Allergy Clin Immunol 1999;103:1049-53.
12. Creticos PS, Adams WP, Petty BG, et al. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered-dose inhalers. J Allergy Clin Immunol 2002;110:713-20.
13. Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR. Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J 2003,2:810-15.
14. Ramsay CM, Cowan J, Flannery E, McLachlan C, Taylor DR. Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma. Eur J Clin Pharmacol 1999;55:353-9.
15. Henderson WR, Banerjee ER, Chi EY. Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. J Allergy Clin Immunol 2005;116:332-40.
16. Agrawal DK, Ariyarathna K, Kelbe PW. (S)-albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 2004;113:503-10.